Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	8,336	8,097	7,702	7,516	7,475	5,772
Revenue Growth (YoY)	4.93%	5.13%	2.48%	0.55%	29.49%	-16.26%
Cost of Revenue	4,373	4,305	4,007	4,136	4,031	3,375
Gross Profit	3,963	3,792	3,695	3,380	3,444	2,397
Selling, General & Admin	1,543	1,498	1,394	1,160	1,045	811.69
Other Operating Expenses	1,083	1,027	795.34	1,047	1,212	502.63
Operating Expenses	2,934	2,819	2,453	2,394	2,431	1,502
Operating Income	1,029	972.66	1,242	986.49	1,013	894.47
Interest Expense	-116.9	-77.5	-60.51	-98.64	-36.93	-43.01
Interest & Investment Income	151.49	151.49	117.9	75.05	88.18	95.79
Currency Exchange Gain (Loss)	160.06	160.06	111.35	77.69	200.57	78.86
Other Non Operating Income (Expenses)	357.79	44.47	44.93	16.48	14.99	15.47
EBT Excluding Unusual Items	1,582	1,251	1,456	1,057	1,280	1,042
Gain (Loss) on Sale of Investments	1.93	1.93	1.72	-	-	-
Gain (Loss) on Sale of Assets	-	-	2.86	3.65	0.68	-0.31
Asset Writedown	-	-	-	-	-3.06	-
Other Unusual Items	-	-	-291.96	-	-735.95	-
Pretax Income	1,587	1,256	1,169	1,061	541.65	1,041
Income Tax Expense	461.67	353.84	352.94	293.37	310.39	301.55
Earnings From Continuing Operations	1,125	902.55	815.78	767.35	231.27	739.72
Net Income to Company	1,125	902.55	815.78	767.35	231.27	739.72
Minority Interest in Earnings	-58.7	-59.56	-61.24	-58.76	-80.86	-54.81
Net Income	1,066	842.99	754.54	708.59	150.4	684.91
Net Income to Common	1,066	842.99	754.54	708.59	150.4	684.91
Net Income Growth	30.90%	11.72%	6.49%	371.13%	-78.04%	-29.58%
Shares Outstanding (Basic)	105	105	104	104	103	103
Shares Outstanding (Diluted)	106	106	106	105	105	105
Shares Change (YoY)	-0.40%	-0.04%	0.56%	0.26%	-0.26%	2.26%
EPS (Basic)	10.14	8.02	7.23	6.83	1.46	6.64
EPS (Diluted)	10.07	7.95	7.11	6.72	1.43	6.49
EPS Growth	31.48%	11.81%	5.80%	369.93%	-77.97%	-31.18%
Free Cash Flow	-	298.48	744.87	-594.86	614.78	548.45
Free Cash Flow Per Share	-	2.81	7.02	-5.64	5.84	5.20
Dividend Per Share	-	0.500	0.500	0.500	0.500	0.500
Gross Margin	47.54%	46.83%	47.98%	44.98%	46.07%	41.52%
Operating Margin	12.35%	12.01%	16.13%	13.13%	13.55%	15.50%
Profit Margin	12.79%	10.41%	9.80%	9.43%	2.01%	11.87%
Free Cash Flow Margin	-	3.69%	9.67%	-7.92%	8.22%	9.50%
EBITDA	1,282	1,223	1,479	1,160	1,166	1,042
EBITDA Margin	15.38%	15.10%	19.20%	15.43%	15.60%	18.06%
D&A For EBITDA	253.17	249.85	236.6	173.54	152.62	147.88
EBIT	1,029	972.66	1,242	986.49	1,013	894.47
EBIT Margin	12.35%	12.01%	16.13%	13.13%	13.55%	15.50%
Effective Tax Rate	29.09%	28.16%	30.20%	27.66%	57.30%	28.96%
Revenue as Reported	9,014	8,462	7,990	7,694	7,789	5,974
Advertising Expenses	-	72.5	84.27	61.7	48.05	18.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.